lemaitre.com (LMAT): Rentabilitas operasi

LeMaitre Corp (LMAT) - logo korporat

LeMaitre Vascular, Inc. (LMAT) maintains an impeccable reputation in vascular surgery based on the reliability of its life-critical implants. The operating margin trend reflects the market's assessment of cost efficiency, where the value 27.70 expresses the current state of the metric. High profitability is driven by patents and global sales. Stable leadership and a debt-free balance sheet ensure exceptional capital management discipline.

LMAT - Rasio bathi operasi LeMaitre Vascular ing rentang 04.07.2022 - 20.11.2026

Rincian metrik komprehensif lan analitis LeMaitre Vascular, Inc. (LMAT)

- rega saham lan konsensus proyeksi valuasi:
Analisis fundamental perusahaan:LMAT, LeMaitre Corp
Barang utama LeMaitre Corp

LeMaitre Vascular, Inc. (LMAT) maintains a diversified portfolio of vascular surgery instruments that ensures operating margin stability, reflecting the profit share from core operations relative to total revenue. An analysis of marginal income from primary activities allows for an assessment of cost management efficiency excluding debt service and taxes, confirming the high resilience of the company's business model to market volatility.

Analisis perusahaan pesaing

ISRG (intuitive.com) - Margin operasi|Rentabilitas dodolan miturut bathi operasi DHR (Danaher Corp.)|Margin dodolan operasi BDX (Becton, Dickinson and Company)|Rasio bathi operasi STE|Rentabilitas operasi West Pharma WST|Rentabilitas kegiatan operasi Baxter (BAX)|MASI - Rentabilitas operasi|Rentabilitas kegiatan operasi Stevanato Group Corp STVN|TFX: Margin operasi|Margin dodolan operasi Merit Medical Systems|Rentabilitas operasi Envista Holdings Corp|Margin dodolan operasi ICU Medical Corp (ICUI)|Rentabilitas operasi DENTSPLY SIRONA Inc. (XRAY)|ATRC (AtriCure Corp) - Tingkat bathi operasi|Margin operasi STAA (STAAR Surgical Co)|ChromaDex Corporation (NAGE) - Rentabilitas dodolan operasi|ZimVie Inc - Margin operasi|Rentabilitas dodolan operasi AngioDynamics|CERS (Cerus Corp) - Margin dodolan operasi|Alpha Teknova, Inc. - Tingkat bathi operasi|MGRM (Monogram Orthopedics Inc.) - Margin operasi|STSS: Tingkat bathi operasi|Margin dodolan operasi INFU (InfuSystem Holdings)|Utah Medical Products, Inc. - Rentabilitas dodolan miturut bathi operasi|Margin operasi KRMD (korumedical.com)|Rentabilitas kegiatan operasi Nyxoah, S.A. (NYXH)|MBOT - Rentabilitas operasi|PDEX (Pro-Dex, Inc.) - Rentabilitas dodolan miturut bathi operasi|ZTEK (Zentek Ltd) - Margin dodolan operasi|ELUT - Rentabilitas kegiatan operasi|MLSS (Milestone Scientific Corporation) - Margin operasi|Rentabilitas dodolan miturut bathi operasi NXGL (NEXGEL, Inc.)|Margin operasi RVP|Margin dodolan operasi Harvard Bioscience HBIO|Margin operasi FEMY (Femasys Corporation)|MHUA - Margin dodolan operasi|POAI - Rentabilitas operasi|Callan JMB (CJMB) - Margin dodolan operasi|ATRI: Margin operasi|NURO - Rentabilitas kegiatan operasi